Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | April 30, 2024 12:31pm

Gainers

  • Akili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday's regular session. The company's market cap stands at $31.4 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock rose 51.83% to $2.06. The company's market cap stands at $2.7 million.
  • Eliem Therapeutics (NASDAQ:ELYM) shares rose 50.0% to $7.53. The company's market cap stands at $208.7 million.
  • GeneDx Hldgs (NASDAQ:WGS) stock moved upwards by 45.99% to $16.06. The market value of their outstanding shares is at $418.4 million. The company's, Q1 earnings came out yesterday.
  • Dare Bioscience (NASDAQ:DARE) stock moved upwards by 22.75% to $0.35. The company's market cap stands at $34.8 million.
  • Lucid Diagnostics (NASDAQ:LUCD) shares moved upwards by 20.7% to $0.91. The market value of their outstanding shares is at $43.7 million.

Losers

  • NRX Pharmaceuticals (NASDAQ:NRXP) shares decreased by 23.9% to $2.7 during Tuesday's regular session. The market value of their outstanding shares is at $28.3 million.
  • Innovative Eyewear (NASDAQ:LUCY) stock decreased by 18.64% to $0.2. The company's market cap stands at $2.5 million.
  • Vaxxinity (NASDAQ:VAXX) shares declined by 17.66% to $0.13. The market value of their outstanding shares is at $16.0 million.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) stock decreased by 16.99% to $2.15. The market value of their outstanding shares is at $83.6 million.
  • Annovis Bio (NYSE:ANVS) stock decreased by 16.83% to $6.05. The market value of their outstanding shares is at $66.7 million.
  • OpGen (NASDAQ:OPGN) shares declined by 15.87% to $0.45. The company's market cap stands at $5.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKLI ANVS BRNS CYCC DARE ELYM LUCD LUCY NRXP OPGN VAXX WGS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist